Amber M Messier1, Robin K Ohls. 1. Division of Neonatology, Department of Pediatrics, University of New Mexico, Albuquerque, New Mexico, USA.
Abstract
PURPOSE OF REVIEW: The use of erythropoiesis-stimulating agents (ESAs) such as erythropoietin and darbepoetin in preterm and term infants has been studied for over 20 years. Recent investigations have explored the potential neuroprotective effects of ESAs. We review the recent clinical trials and experimental animal models that provide evidence in support of using ESA to improve the neurodevelopmental outcomes in term and preterm infants. RECENT FINDINGS: Continued work using animal models have confirmed the neuroprotective properties of ESAs, including promotion of oligodendrocyte development in the face of neuronal injury. Clinical studies in term and preterm infants have reported the neuroprotective effects following ESA administration, and improved neurodevelopmental outcomes have been reported in the studies of preterm infants. SUMMARY: ESAs show great promise in preventing and treating brain injury in term and preterm infants.
PURPOSE OF REVIEW: The use of erythropoiesis-stimulating agents (ESAs) such as erythropoietin and darbepoetin in preterm and term infants has been studied for over 20 years. Recent investigations have explored the potential neuroprotective effects of ESAs. We review the recent clinical trials and experimental animal models that provide evidence in support of using ESA to improve the neurodevelopmental outcomes in term and preterm infants. RECENT FINDINGS: Continued work using animal models have confirmed the neuroprotective properties of ESAs, including promotion of oligodendrocyte development in the face of neuronal injury. Clinical studies in term and preterm infants have reported the neuroprotective effects following ESA administration, and improved neurodevelopmental outcomes have been reported in the studies of preterm infants. SUMMARY: ESAs show great promise in preventing and treating brain injury in term and preterm infants.
Authors: Peter T Tsai; John J Ohab; Nathalie Kertesz; Matthias Groszer; Cheryl Matter; Jing Gao; Xin Liu; Hong Wu; S Thomas Carmichael Journal: J Neurosci Date: 2006-01-25 Impact factor: 6.167
Authors: E Bryl; J Myśliwska; A Debska-Slizień; D Rachoń; B Bułło; S Lizakowski; A Myśliwski; B Rutkowski Journal: Artif Organs Date: 1998-03 Impact factor: 3.094
Authors: Nicoletta Kessaris; Matthew Fogarty; Palma Iannarelli; Matthew Grist; Michael Wegner; William D Richardson Journal: Nat Neurosci Date: 2005-12-25 Impact factor: 24.884
Authors: Charles Gasparovic; Arvind Caprihan; Ronald A Yeo; John Phillips; Jean R Lowe; Richard Campbell; Robin K Ohls Journal: Pediatr Radiol Date: 2018-01-15